Biophytis【ALBPS】銘柄情報

Biophytis (ALBPS) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.0153

( -7.27% )

買値

0.0151

売値

0.017

出来高

1,911,913

0.0153 日の範囲 0.0168

0.0153 52 週間の範囲 0.2075

時価総額

1.402M

前日終値

0.0165

始値

0.0165

時刻

85000

0.0153

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

5,038,275 €

発行済株式数

91,622,088

配当利回り

PER

-0.03

1 株当たり利益 (EPS)

-0.61

歳入

純利益

-8.03M

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases. The company’s lead drug candidate is the BIO101 to treat obesity, respiratory infections due... Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases. The company’s lead drug candidate is the BIO101 to treat obesity, respiratory infections due to Covid-19, sarcopenia, and Duchenne Muscular Dystrophy (DMD). It has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD. It also has an alliance with LynxKite Technologies Pte Ltd for the development of AI-driven drug discovery for longevity therapies. The company was incorporated in 2006 and is headquartered in Paris, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.biophytis.com

本社

Paris, France

設立

2026

Biophytis is listed in the Healthcare sector of the ユーロネクスト with ticker ALBPS. The last closing price for Biophytis was 0.02 €. Over the last year, Biophytis shares have traded in a share price range of 0.0153 € to 0.2075 €.

Biophytis currently has 91,622,088 shares in issue. The market capitalisation of Biophytis is 1.40 € million. Biophytis has a price to earnings ratio (PE ratio) of -0.03.

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Biophytis to Restate Previously Issued Financial Statements

PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth...

Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patien...

PARIS and CAMBRIDGE, Mass., July 02, 2020 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a...

Biophytis Announces Three Oral and One Poster Presentations at the 2019 International Conference on Frailty and Sarcopenia Re...

PARIS, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0037	-19.4736842105	0.019	0.0213	0.0153	3577007	0.01748265	DE
4	-0.0057	-27.1428571429	0.021	0.0233	0.0153	2919343	0.01927253	DE
12	-0.0127	-45.3571428571	0.028	0.0338	0.0153	4402501	0.02160423	DE
26	-0.0657	-81.1111111111	0.081	0.1098	0.0153	2666424	0.02991613	DE
52	-0.1197	-88.6666666667	0.135	0.2075	0.0153	1521413	0.03645854	DE
156	-0.0065	-29.8165137615	0.0218	1.4	0.0021	4960886	0.0127099	DE
260	-0.8999	-98.3282342657	0.9152	1.4	0.0021	3888240	0.05700982	DE